<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Michael Regan | Activity</title>
	<link>http://toxicdolls.com/members/cakekale93/activity/</link>
	<atom:link href="http://toxicdolls.com/members/cakekale93/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Michael Regan.</description>
	<lastBuildDate>Sun, 08 Nov 2026 17:11:27 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">068d3361831079d83ade6fdce1ae3259</guid>
				<title>Michael Regan posted an update: 7% (6/90). The prevalence of karyotypic abnormalities or FMR1 [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/55703/</link>
				<pubDate>Tue, 15 Jul 2025 10:32:25 +0000</pubDate>

									<content:encoded><![CDATA[<p>7% (6/90). The prevalence of karyotypic abnormalities or FMR1 premutation did not differ significantly between familial and sporadic cases. Neither chromosome abnormalities nor FMR1 premutation influenced age at menopause or follicle stimulating hormone levels at diagnosis in premature ovarian insufficiency patients.</p>
<p> This is the first&hellip;<span class="activity-read-more" id="activity-read-more-55703"><a href="http://toxicdolls.com/activity-2/p/55703/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">821c8680efcafdf45eb3856f61bcd8f7</guid>
				<title>Michael Regan posted an update: 38 hours). A flat exposure-response was observed, confirming [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/41107/</link>
				<pubDate>Thu, 10 Jul 2025 14:00:56 +0000</pubDate>

									<content:encoded><![CDATA[<p>38 hours). A flat exposure-response was observed, confirming that the relationship plateaued at the level of exposure observed in pediatric patients. Simulations confirmed that weight band-based dosing regimens (10 mg [12-25 kg], 15 mg [26-40 kg], 20 mg [41-50 kg], 25 mg [51-65 kg], and 30 mg [&gt;65 kg]) resulted in exposure similar to the 0.4-mg/kg&hellip;<span class="activity-read-more" id="activity-read-more-41107"><a href="http://toxicdolls.com/activity-2/p/41107/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cca55c65dd18b49b5648307e8ebb290a</guid>
				<title>Michael Regan became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/40987/</link>
				<pubDate>Thu, 10 Jul 2025 13:13:50 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>